 |
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic radiopharmaceutical candidate for treating pain associated with bone metastasis.
TLX...
Read more: Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
Hashtag.net.au
For many people, dental anxiety isn’t just a minor worry — it’s a barrier that keeps them from getting the care they need. The sound of drills, the sterile scent, or even a simple check-up can cause h...
Hashtag.net.au
Getting a restful night's sleep is essential for overall health and well-being. For many, external noises—be it a snoring partner, traffic, or noisy neighbors—can disrupt sleep patterns. One effective...
Hashtag.net.au
Adolescence is often described as a turbulent period of life. Hormonal changes, social pressures, academic stress, and the search for identity all combine to make the teenage years emotionally inten...